Trial Information
Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage
Inclusion Criteria:
- Non traumatic SAH documented by CT scan
- Patient with SAH who would need external ventricular drain (EVD) for the management
of hydrocephalus
- Patients with normal pressure Hydrocephalus that require an external drain
- Control (non - hemorrhagic) group - CSF collected from patients with posterior fossa
tumor or stroke with EVD in place for the management of hydrocephalus.
Exclusion Criteria:
- Recent infection within last 1 month of presentation- can increase inflammatory
markers
- Recent surgery or acute myocardial infarction within last 1 month of presentation
- Age > 89 years or < 18 years
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Protein identification and concentration
Outcome Time Frame:
For the duration of CSF drainage, or until the 21st day after admission.
Safety Issue:
No
Principal Investigator
Eric M Deshaies, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
SUNY Upstate Medical University - Neurosurgery
Authority:
United States: Institutional Review Board
Study ID:
IRB#225490
NCT ID:
NCT01799018
Start Date:
April 2011
Completion Date:
April 2013
Related Keywords:
- Subarachnoid Hemorrhage
- Cerebral Vasospasm
- Hydrocephalus
- Xanthine Oxidase
- Cerebrospinal fluid
- Hemorrhage
- Hydrocephalus
- Subarachnoid Hemorrhage
- Vasospasm, Intracranial
Name | Location |
State University of New York Upstate Medical University |
Syracuse, New York 13210 |